Company builder

Several months after Vatera Holdings became Rib-X Pharmaceuticals Inc.'s biggest backer, the firm has now installed a handpicked CEO and new commercial head. The moves suggest any plans for a public exit have taken a backseat to building a commercial organization for the antibiotic delafloxacin.